Literature DB >> 28604349

Tumor Necrosis Factor Inhibitors Provide Longterm Clinical Benefits in Pediatric and Young Adult Patients with Blau Syndrome.

Tomokazu Nagakura1, Hiroyuki Wakiguchi2, Tomohiro Kubota3, Tsuyoshi Yamatou3, Yuichi Yamasaki3, Yukiko Nonaka3, Yasuhito Nerome3, Harumi Akaike3, Tomoko Takezaki3, Hiroyuki Imanaka3, Yoshifumi Kawano3, Syuji Takei4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28604349     DOI： 10.3899/jrheum.160672

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  11 in total

Review 1.  Monogenic autoinflammatory disorders: Conceptual overview, phenotype, and clinical approach.

Authors:  Peter A Nigrovic; Pui Y Lee; Hal M Hoffman
Journal:  J Allergy Clin Immunol       Date:  2020-11       Impact factor: 10.793

Review 2.  Biologic Therapies for the Management of Cutaneous Findings in Genodermatoses: A Review.

Authors:  Tejas P Joshi; Hannah Y Wang; Prazwal Athukuri; Sarah Bohac; Morgan A Farr; Darien Hinson; Justin A Kahla; Nasim Khalfe; Dylan B McBee; Rachel Stroh; Nicole Walters; Vicky Ren
Journal:  Am J Clin Dermatol       Date:  2022-05-23       Impact factor: 6.233

Review 3.  Induced Pluripotent Stem Cell-Derived Monocytes/Macrophages in Autoinflammatory Diseases.

Authors:  Takayuki Tanaka; Takeshi Shiba; Yoshitaka Honda; Kazushi Izawa; Takahiro Yasumi; Megumu K Saito; Ryuta Nishikomori
Journal:  Front Immunol       Date:  2022-05-06       Impact factor: 8.786

Review 4.  Potential Benefits of TNF Targeting Therapy in Blau Syndrome, a NOD2-Associated Systemic Autoinflammatory Granulomatosis.

Authors:  Tomoko Matsuda; Naotomo Kambe; Riko Takimoto-Ito; Yoko Ueki; Satoshi Nakamizo; Megumu K Saito; Syuji Takei; Nobuo Kanazawa
Journal:  Front Immunol       Date:  2022-05-27       Impact factor: 8.786

5.  Blau Syndrome and Early-Onset Sarcoidosis: A Six Case Series and Review of the Literature.

Authors:  Ayşenur PaÇ Kisaarslan; Betül SÖzerİ; Nihal Şahİn; Sümeyra Özdemİr ÇİÇek; Zübeyde GÜndÜz; Erkan Demİrkaya; Afig Berdelİ; Serdal Sadet Özcan; Hakan PorazoĞlu; Ruhan DÜŞÜnsel
Journal:  Arch Rheumatol       Date:  2019-11-06       Impact factor: 1.472

Review 6.  Monogenic Autoinflammatory Diseases: State of the Art and Future Perspectives.

Authors:  Giulia Di Donato; Debora Mariarita d'Angelo; Luciana Breda; Francesco Chiarelli
Journal:  Int J Mol Sci       Date:  2021-06-14       Impact factor: 5.923

7.  Effective treatment of TNFα inhibitors in Chinese patients with Blau syndrome.

Authors:  Jing Chen; Yi Luo; Mengzhu Zhao; Di Wu; Yunjiao Yang; Wen Zhang; Min Shen
Journal:  Arthritis Res Ther       Date:  2019-11-12       Impact factor: 5.156

8.  Ophthalmological treatment of early-onset sarcoidosis/Blau syndrome in a Colombian child: A case report.

Authors:  María Alejandra Marín-Noriega; Juliana Muñoz-Ortiz; Catalina Mosquera; Alejandra de-la-Torre
Journal:  Am J Ophthalmol Case Rep       Date:  2020-04-18

9.  Giant Cell Tumor of Tendon Sheath and Tendinopathy as Early Features of Early Onset Sarcoidosis.

Authors:  Shaoling Zheng; Pui Y Lee; Yukai Huang; Aiwu Wang; Tianwang Li
Journal:  Front Pediatr       Date:  2019-11-15       Impact factor: 3.418

10.  A novel mutation in early-onset sarcoidosis/Blau syndrome: an association with Propionibacterium acnes.

Authors:  Fumiko Okazaki; Hiroyuki Wakiguchi; Yuno Korenaga; Tamaki Nakamura; Hiroki Yasudo; Shohei Uchi; Ryoji Yanai; Nobuyuki Asano; Yoshinobu Hoshii; Tsuyoshi Tanabe; Kazushi Izawa; Yoshitaka Honda; Ryuta Nishikomori; Keisuke Uchida; Yoshinobu Eishi; Shouichi Ohga; Shunji Hasegawa
Journal:  Pediatr Rheumatol Online J       Date:  2021-02-18       Impact factor: 3.054
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.